SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mohan Gurjar, Risk Factors for Anticoagulant Thromboprophylaxis Failure in Critically Ill Patients, Critical Care Medicine, 2015, 43, 6, e216

    CrossRef

  2. 2
    Kunihiro Hosaka, Shu Saito, Takao Ishii, Takanobu Sumino, Keinosuke Ryu, Gen Suzuki, Takashi Suzuki, Yasuaki Tokuhashi, Safety of Fondaparinux Versus Enoxaparin After TKA in Japanese Patients, Orthopedics, 2013, 36, 4, e428

    CrossRef

  3. 3
    J. BEYER-WESTENDORF, J. LÜTZNER, L. DONATH, O. C. RADKE, E. KUHLISCH, A. HARTMANN, N. WEISS, S. WERTH, Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry, Journal of Thrombosis and Haemostasis, 2012, 10, 10
  4. 4
    J. Beyer-Westendorf, J. Lützner, L. Donath, L. Tittl, H. Knoth, O. C. Radke, E. Kuhlisch, T. Stange, A. Hartmann, K.-P. Günther, N. Weiss, S. Werth, Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery, Thrombosis and Haemostasis, 2012, 109, 1, 154

    CrossRef